COMPASS study for metastatic castration-resistant prostate cancer - Clinical Trial

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
COMPASS: Correlative COMPAnion Study to Predict SYNERGY-201 Clinical Trial Responders
Principal Investigator
Andrew J. Armstrong, MD, MSc
Medical Oncologist
Protocol Number
IRB: PRO00115687
NCT: NCT07050433
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Support Duke Health research or honor a loved one with a tribute gift.